Skip to main content

Advertisement

Table 2 Prevalence of molecular markers associated with P. falciparum resistance to SP in IPTi intervention and non-intervention zone in Kolokani at baseline in May 2007.

From: Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali

  No IPTi IPTi p
Molecular Markers n Prevalence n Prevalence  
DHPS 437 333 20.1% 315 17.5% 0.39
DHPS 540 265 0.4% 313 1.6% 0.22
DHFR 51 209 35.4% 216 38.4% 0.52
DHFR 59 220 48.2% 206 47.6% 0.90
DHFR 108 223 43.0% 242 38.0% 0.27
Triple DHFR mutation 179 34.6% 184 35.8% 0.81
Quadruple mutation 161 8.1% 174 10.3% 0.47